GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd (SHSE:600329) » Definitions » Accounts Receivable

Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Accounts Receivable : ¥1,086 Mil (As of Mar. 2025)


View and export this data going back to 2001. Start your Free Trial

What is Tianjin Pharmaceutical Da Ren Tang Group Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Tianjin Pharmaceutical Da Ren Tang Group's accounts receivables for the quarter that ended in Mar. 2025 was ¥1,086 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Tianjin Pharmaceutical Da Ren Tang Group's Days Sales Outstanding for the quarter that ended in Mar. 2025 was 68.07.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Tianjin Pharmaceutical Da Ren Tang Group's Net-Net Working Capital per share for the quarter that ended in Mar. 2025 was ¥-0.10.


Tianjin Pharmaceutical Da Ren Tang Group Accounts Receivable Historical Data

The historical data trend for Tianjin Pharmaceutical Da Ren Tang Group's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tianjin Pharmaceutical Da Ren Tang Group Accounts Receivable Chart

Tianjin Pharmaceutical Da Ren Tang Group Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Accounts Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,512.81 1,536.99 2,146.21 2,172.70 756.29

Tianjin Pharmaceutical Da Ren Tang Group Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Accounts Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,586.84 2,598.00 2,372.32 756.29 1,085.58

Tianjin Pharmaceutical Da Ren Tang Group Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.


Tianjin Pharmaceutical Da Ren Tang Group Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Tianjin Pharmaceutical Da Ren Tang Group's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=1085.575/1455.3*91
=68.07

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Tianjin Pharmaceutical Da Ren Tang Group's accounts receivable are only considered to be worth 75% of book value:

Tianjin Pharmaceutical Da Ren Tang Group's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2025 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(1454.568+0.75 * 1085.575+0.5 * 1204.909-2946.26
-0-3.882)/770.094
=-0.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


Tianjin Pharmaceutical Da Ren Tang Group Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Tianjin Pharmaceutical Da Ren Tang Group's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Tianjin Pharmaceutical Da Ren Tang Group Business Description

Traded in Other Exchanges
Address
No. 17 Baidi Road, Da Ren Tang Mansion, Nankai District, Tianjin, CHN, 300193
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is a pharmaceutical manufacturing company. The company manufactures and sells traditional Chinese medicine, western medicine, and healthcare products in the People's Republic of China. It operates in two segments, namely the Chinese Medicine segment and the Western Medicine segment. The Chinese Medicine segment manufactures Chinese pharmaceutical products under brands owned by the group. The Western Medicine segment manufactures Western pharmaceutical products through cooperation with foreign companies. The company earns the majority of its revenue from the sale of Chinese pharmaceutical products.
Executives
Li Li Qun Director
Ni Zhen Guo senior management
Yu Hong Directors, senior managers
Zhou Hong Directors, senior managers
Zhang Jian senior management
Niu Sheng Fang senior management
Wang Xin senior management
Wang Mai Director
Jiao Yan senior management
Hao Fei Fei Director
Zhang Bao Tong senior management
Wang Zhi Qiang senior management
Liang Xiu Qin senior management
Li Jia Sheng Supervisors
Zhang Hong Kui Director

Tianjin Pharmaceutical Da Ren Tang Group Headlines

No Headlines